Иновацията във фармацията има смисъл само, когато достига до нуждаещите се от нея. Ние #НямаДаСпрем докато достиженията на науката не станат достъпни за българските пациенти.
През следващите години фармацевтичната индустрия ще разработи нови терапии за нерешените проблеми в онкологията, диабета, хемофилията, болест на Алцхаймер, инфекциите, чернодробни заболявания, мигрената. Ние #НямаДаСпрем, докато не осигурим шанс на всеки български пациент да се лекува с най-добрите терапии.
We Won’t Rest until our innovative medicines are made available to all eligible cancer patients worldwide.
#WeWontRest until we have found a cure for Type 1 Diabetes.
Director Medical Affairs Infectious Diseases, MSD.
#WeWontRest until we develop transformational vaccines to prevent, intercept, treat and cure life-threatening infectious diseases.
#WeWontRest until every cancer patient can return to a normal life.
As precision medicine opens new doors in the treatment of cancer, we must overcome challenges in finding the right patient for the right treatment. #WeWontRest until patients can be considered for multiple trials on the basis of a single molecular screening.
We won't rest in research to develop new drugs that can cure diseases that still do not have effective solutions.
#WeWontRest until hepatitis C is eliminated.
#WeWontRest until we live in a world in which no one suffers or dies from a vaccine-preventable disease.
#WeWontRest. Migraine matters and we are committed to working with the migraine community to discover new ways to improve people’s lives and give patients the voice they deserve.
#WeWontRest until we unlock data sets all over Europe that will drive research and shape more effective patient care.
I won’t rest until patients can use their smartphones to give us trial feedback in real time.
#WeWontRest until we have the best teams working together to find new innovative therapies that help patients live longer and healthier lives.
#WeWontRest until we include patient insights in the planning of every clinical program.
#WeWontRest to support and conduct clinical trials until diseases have lost their negative impact on human lives.
We have advanced science and medicine to provide a cure for Hepatitis C and #WeWontRest until we have eliminated it.
#WeWontRest until not one person loses their life to a vaccine-preventable illness.
#WeWontRest until we bring new advances and pioneering therapies in migraine to the patients that need them the most worldwide.
#WeWontRest until health is embedded in all policies, to achieve healthier lives at all ages and stages, wherever we live.
#WeWontRest until we have helped asthma patients to #LiveEveryBreath.
#WeWontRest while opportunities exist to leverage innovative technologies to ensure the safety and wellbeing of our patients.
#WeWontRest in our objective to transform the way cancer is treated allowing patients to achieve better health results and better quality of life.
#WeWontRest in our Research efforts to bring innovative medicines that makes a real difference to all patients’ lives.
#WeWontRest until we incorporate the patient voice in the treatment decision making process and ensure patients as key stakeholders.
#WeWontRest until diagnosis becomes easier for every disease.
#WeWontRest until we have helped eradicate all vaccine-preventable diseases.
The World Health Organisation (WHO) places migraine as the top 10 of the most disabling diseases. #WeWontRest until migraine becomes a manageable condition.
#WeWontRest to ensure that our medicines, clinical trials and services meet the expectations of patients and patient organisations.
#WeWontRest until insights from individual patient experiences of living with and managing disease are built into every part of the lifecycle of our medicines and vaccines.
#WeWontRest in our endeavor to find innovative solutions that make a difference in the lives of patients affected by serious medical conditions.
#WeWontRest until all of the outstanding unmet need across the spectrum of SMA disease is addressed and the full impact of treatment is fully understood.
#WeWontRest until we make it possible for every eligible patient to participate in a clinical trial – irrespective their location, socio-economic status, age, mobility - and we make this participation an all-round positive experience for them.
Alzheimer’s: forgetting what was so obvious before. We continue to strive to find a treatment that modifies the course of the disease and #WeWontRest until we do so.